Michael Andrew Chambers insider trades: Sarepta Therapeutics (SRPT) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | SRPT | ↑ Buy | 37,038 | $133.80 | $5.0M | By Revocable Trust | Aug 20, 2024 (4d) |
| Aug 14, 2023 | SRPT | ↑ Buy | 9,979 | $109.47 | $1.1M | By Revocable Trust | Aug 15, 2023 (1d) |
| Aug 11, 2023 | SRPT | ↑ Buy | 23,686 | $108.05 | $2.6M | By Revocable Trust | Aug 14, 2023 (3d) |
| Aug 10, 2023 | SRPT | ↑ Buy | 34,867 | $106.15 | $3.7M | By Revocable Trust | Aug 11, 2023 (1d) |
| Sep 14, 2022 | SRPT | ↑ Buy | 57,100 | $104.43 | $6.0M | Direct | Sep 15, 2022 (1d) |
| Aug 19, 2022 | SRPT | ↑ Buy | 46,170 | $108.28 | $5.0M | Direct | Aug 22, 2022 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SRPT insiders
Open-market trades in the last 12 months
About Michael Andrew Chambers's insider trades
Michael Andrew Chambers is an insider at Sarepta Therapeutics (SRPT). Since Aug 19, 2022, Michael has reported 6 open-market purchases worth $23.3M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SRPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.